{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:18:26Z","timestamp":1788023906246,"version":"build-2784847793"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying initial triggering events in neurodegenerative disorders is critical to developing preventive therapies. In Huntington\u2019s disease (HD), hyperdopaminergia\u2014probably triggered by the dysfunction of the most affected neurons, indirect pathway spiny projection neurons (iSPNs)\u2014is believed to induce hyperkinesia, an early stage HD symptom. However, how this change arises and contributes to HD pathogenesis is unclear. Here, we demonstrate that genetic disruption of iSPNs function by <jats:italic>Ntrk2\/Trkb<\/jats:italic> deletion in mice results in increased striatal dopamine and midbrain dopaminergic neurons, preceding hyperkinetic dysfunction. Transcriptomic analysis of iSPNs at the pre-symptomatic stage showed de-regulation of metabolic pathways, including upregulation of <jats:italic>Gsto2<\/jats:italic>, encoding glutathione S-transferase omega-2 (GSTO2). Selectively reducing <jats:italic>Gsto2<\/jats:italic> in iSPNs in vivo effectively prevented dopaminergic dysfunction and halted the onset and progression of hyperkinetic symptoms. This study uncovers a functional link between altered iSPN BDNF-TrkB signalling, glutathione\u2013ascorbate metabolism and hyperdopaminergic state, underscoring the vital role of GSTO2 in maintaining dopamine balance.<\/jats:p>","DOI":"10.1038\/s42255-024-01155-z","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:04:59Z","timestamp":1730113499000},"page":"2100-2117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impaired striatal glutathione\u2013ascorbate metabolism induces transient dopamine increase and motor dysfunction"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5514-0364","authenticated-orcid":false,"given":"Mohd Yaseen","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-5462","authenticated-orcid":false,"given":"Fei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Asif-Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-8232","authenticated-orcid":false,"given":"Vasileios","family":"Eftychidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Barkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-2194","authenticated-orcid":false,"given":"Elena","family":"Eliseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-7518","authenticated-orcid":false,"given":"Kerstin N.","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bergin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Zonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7089-5765","authenticated-orcid":false,"given":"Veronika","family":"Ratz-Wirsching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-0664","authenticated-orcid":false,"given":"Stephan","family":"von H\u00f6rsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0117-2894","authenticated-orcid":false,"given":"Mark E.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7141-7071","authenticated-orcid":false,"given":"Peter J.","family":"Magill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Nerlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-4765","authenticated-orcid":false,"given":"Liliana","family":"Minichiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"1155_CR1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","volume":"34","author":"CR Gerfen","year":"2011","unstructured":"Gerfen, C. R. & Surmeier, D. J. Modulation of striatal projection systems by dopamine. Annu. Rev. Neurosci. 34, 441\u2013466 (2011).","journal-title":"Annu. Rev. Neurosci."},{"key":"1155_CR2","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.112","volume":"2","author":"D Bano","year":"2011","unstructured":"Bano, D., Zanetti, F., Mende, Y. & Nicotera, P. Neurodegenerative processes in Huntington\u2019s disease. Cell Death Dis. 2, e228 (2011).","journal-title":"Cell Death Dis."},{"key":"1155_CR3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev.pa.20.040180.002533","volume":"20","author":"ED Bird","year":"1980","unstructured":"Bird, E. D. Chemical pathology of Huntington\u2019s disease. Annu. Rev. Pharmacol. Toxicol. 20, 533\u2013551 (1980).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1155_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","volume":"103","author":"EG Spokes","year":"1980","unstructured":"Spokes, E. G. Neurochemical alterations in Huntington\u2019s chorea: a study of post-mortem brain tissue. Brain 103, 179\u2013210 (1980).","journal-title":"Brain"},{"key":"1155_CR5","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jnr.24495","volume":"97","author":"ET Koch","year":"2019","unstructured":"Koch, E. T. & Raymond, L. A. Dysfunctional striatal dopamine signaling in Huntington\u2019s disease. J. Neurosci. Res. 97, 1636\u20131654 (2019).","journal-title":"J. Neurosci. Res."},{"key":"1155_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101, 57\u201366 (2000).","journal-title":"Cell"},{"key":"1155_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","volume":"12","author":"S von Horsten","year":"2003","unstructured":"von Horsten, S. et al. Transgenic rat model of Huntington\u2019s disease. Hum. Mol. Genet. 12, 617\u2013624 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"1155_CR8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0962-8924(00)01853-5","volume":"10","author":"AJ Tobin","year":"2000","unstructured":"Tobin, A. J. & Signer, E. R. Huntington\u2019s disease: the challenge for cell biologists. Trends Cell Biol. 10, 531\u2013536 (2000).","journal-title":"Trends Cell Biol."},{"key":"1155_CR9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","volume":"27","author":"MS Levine","year":"2004","unstructured":"Levine, M. S., Cepeda, C., Hickey, M. A., Fleming, S. M. & Chesselet, M. F. Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: illuminating but imperfect. Trends Neurosci. 27, 691\u2013697 (2004).","journal-title":"Trends Neurosci."},{"key":"1155_CR10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato, C. & Cattaneo, E. Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog. Neurobiol. 81, 294\u2013330 (2007).","journal-title":"Prog. Neurobiol."},{"key":"1155_CR11","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner, A. et al. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl Acad. Sci. USA 85, 5733\u20135737 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1155_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano, M., Galvan, L., Deglon, N. & Brouillet, E. Mitochondria in Huntington\u2019s disease. Biochim. Biophys. Acta 1802, 52\u201361 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"1155_CR13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3031","volume":"4","author":"D Besusso","year":"2013","unstructured":"Besusso, D. et al. BDNF\u2013TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior. Nat. Commun. 4, 2031 (2013).","journal-title":"Nat. Commun."},{"key":"1155_CR14","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","volume":"98","author":"X Zhuang","year":"2001","unstructured":"Zhuang, X. et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl Acad. Sci. USA 98, 1982\u20131987 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1155_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-328X(02)00555-7","volume":"110","author":"C Cannizzaro","year":"2003","unstructured":"Cannizzaro, C., Tel, B. C., Rose, S., Zeng, B. Y. & Jenner, P. Increased neuropeptide Y mRNA expression in striatum in Parkinson\u2019s disease. Brain Res. Mol. Brain Res. 110, 169\u2013176 (2003).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"1155_CR16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","volume":"340","author":"D Dawbarn","year":"1985","unstructured":"Dawbarn, D., De Quidt, M. E. & Emson, P. C. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington\u2019s disease. Brain Res. 340, 251\u2013260 (1985).","journal-title":"Brain Res."},{"key":"1155_CR17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0306-4522(88)90101-7","volume":"26","author":"L Kerkerian","year":"1988","unstructured":"Kerkerian, L., Salin, P. & Nieoullon, A. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Neuroscience 26, 809\u2013817 (1988).","journal-title":"Neuroscience"},{"key":"1155_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.regpep.2005.01.005","volume":"129","author":"AS Adewale","year":"2005","unstructured":"Adewale, A. S., Macarthur, H. & Westfall, T. C. Neuropeptide Y induced modulation of dopamine synthesis in the striatum. Regul. Pept. 129, 73\u201378 (2005).","journal-title":"Regul. Pept."},{"key":"1155_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171\u2013181 (2014).","journal-title":"Nat. Protoc."},{"key":"1155_CR20","unstructured":"Vatanashevanopakorn, C. et al. in Neuromethods, Vol. 143 (eds Duarte, C. & Tongiorgi, E.) 55\u201376 (Humana, 2017)."},{"key":"1155_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"1155_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41593-018-0075-7","volume":"21","author":"MB Victor","year":"2018","unstructured":"Victor, M. B. et al. Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat. Neurosci. 21, 341\u2013352 (2018).","journal-title":"Nat. Neurosci."},{"key":"1155_CR23","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20167435","volume":"14","author":"SA Ament","year":"2018","unstructured":"Ament, S. A. et al. Transcriptional regulatory networks underlying gene expression changes in Huntington\u2019s disease. Mol. Syst. Biol. 14, e7435 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"1155_CR24","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1155_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes, J. D., Flanagan, J. U. & Jowsey, I. R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51\u201388 (2005).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1155_CR26","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu, S. C. Glutathione synthesis. Biochim. Biophys. Acta 1830, 3143\u20133153 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"1155_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-7-13","volume":"7","author":"M Allen","year":"2012","unstructured":"Allen, M. et al. Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol. Neurodegener. 7, 13 (2012).","journal-title":"Mol. Neurodegener."},{"key":"1155_CR28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/03602532.2011.561353","volume":"43","author":"PG Board","year":"2011","unstructured":"Board, P. G. The omega-class glutathione transferases: structure, function, and genetics. Drug Metab. Rev. 43, 226\u2013235 (2011).","journal-title":"Drug Metab. Rev."},{"key":"1155_CR29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.neurobiolaging.2005.05.013","volume":"27","author":"YJ Li","year":"2006","unstructured":"Li, Y. J. et al. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases. Neurobiol. Aging 27, 1087\u20131093 (2006).","journal-title":"Neurobiol. Aging"},{"key":"1155_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00439-008-0487-7","volume":"123","author":"N Heisterkamp","year":"2008","unstructured":"Heisterkamp, N., Groffen, J., Warburton, D. & Sneddon, T. P. The human gamma-glutamyltransferase gene family. Hum. Genet. 123, 321\u2013332 (2008).","journal-title":"Hum. Genet."},{"key":"1155_CR31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang, S., Wang, R. & Wang, G. Impact of dopamine oxidation on dopaminergic neurodegeneration. ACS Chem. Neurosci. 10, 945\u2013953 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"1155_CR32","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1155_CR33","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00204-016-1691-1","volume":"90","author":"PG Board","year":"2016","unstructured":"Board, P. G. & Menon, D. Structure, function and disease relevance of omega-class glutathione transferases. Arch. Toxicol. 90, 1049\u20131067 (2016).","journal-title":"Arch. Toxicol."},{"key":"1155_CR34","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/nprot.2006.378","volume":"1","author":"I Rahman","year":"2006","unstructured":"Rahman, I., Kode, A. & Biswas, S. K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat. Protoc. 1, 3159\u20133165 (2006).","journal-title":"Nat. Protoc."},{"key":"1155_CR35","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1073\/pnas.1831768100","volume":"100","author":"M Cyr","year":"2003","unstructured":"Cyr, M. et al. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc. Natl Acad. Sci. USA 100, 11035\u201311040 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1155_CR36","first-page":"209","volume":"4","author":"F Nualart","year":"2014","unstructured":"Nualart, F. et al. Vitamin C transporters, recycling and the bystander effect in the nervous system: SVCT2 versus Gluts. J. Stem Cell Res. Ther. 4, 209 (2014).","journal-title":"J. Stem Cell Res. Ther."},{"key":"1155_CR37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0891-5849(94)90019-1","volume":"17","author":"BS Winkler","year":"1994","unstructured":"Winkler, B. S., Orselli, S. M. & Rex, T. S. The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Radic. Biol. Med. 17, 333\u2013349 (1994).","journal-title":"Free Radic. Biol. Med."},{"key":"1155_CR38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","volume":"46","author":"FE Harrison","year":"2009","unstructured":"Harrison, F. E. & May, J. M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 46, 719\u2013730 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"1155_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(98)00129-3","volume":"244","author":"G Seitz","year":"1998","unstructured":"Seitz, G. et al. Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neurosci. Lett. 244, 33\u201336 (1998).","journal-title":"Neurosci. Lett."},{"key":"1155_CR40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2013.09.040","volume":"1539","author":"ME Meredith","year":"2013","unstructured":"Meredith, M. E. & May, J. M. Regulation of embryonic neurotransmitter and tyrosine hydroxylase protein levels by ascorbic acid. Brain Res. 1539, 7\u201314 (2013).","journal-title":"Brain Res."},{"key":"1155_CR41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/B978-0-12-802206-1.00027-1","volume":"24","author":"SN Haber","year":"2016","unstructured":"Haber, S. N. Integrative networks across basal ganglia circuits. Handb. Behav. Neurosci. 24, 535\u2013552 (2016).","journal-title":"Handb. Behav. Neurosci."},{"key":"1155_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbrc.2008.06.120","volume":"374","author":"VS Subramanian","year":"2008","unstructured":"Subramanian, V. S., Marchant, J. S., Reidling, J. C. & Said, H. M. N-Glycosylation is required for Na+-dependent vitamin C transporter functionality. Biochem. Biophys. Res. Commun. 374, 123\u2013127 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1155_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08453-1","volume":"10","author":"K Tiklova","year":"2019","unstructured":"Tiklova, K. et al. Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain development. Nat. Commun. 10, 581 (2019).","journal-title":"Nat. Commun."},{"key":"1155_CR44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature17996","volume":"534","author":"P Tovote","year":"2016","unstructured":"Tovote, P. et al. Midbrain circuits for defensive behaviour. Nature 534, 206\u2013212 (2016).","journal-title":"Nature"},{"key":"1155_CR45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70217","volume":"11","author":"SA Shenoy","year":"2022","unstructured":"Shenoy, S. A. et al. A novel and accurate full-length HTT mouse model for Huntington\u2019s disease. eLife 11, e70217 (2022).","journal-title":"eLife"},{"key":"1155_CR46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/NEN.0b013e3181ee005d","volume":"69","author":"A Jahanshahi","year":"2010","unstructured":"Jahanshahi, A. et al. Hyperdopaminergic status in experimental Huntington disease. J. Neuropathol. Exp. Neurol. 69, 910\u2013917 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1155_CR47","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-019-0581-9","volume":"12","author":"F Agus","year":"2019","unstructured":"Agus, F., Crespo, D., Myers, R. H. & Labadorf, A. The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington\u2019s disease brain. BMC Med. Genomics 12, 137 (2019).","journal-title":"BMC Med. Genomics"},{"key":"1155_CR48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","volume":"107","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Cell type-specific transcriptomics reveals that mutant Huntingtin leads to mitochondrial RNA release and neuronal innate immune activation. Neuron 107, 891\u2013908.e8 (2020).","journal-title":"Neuron"},{"key":"1155_CR49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1188472","volume":"330","author":"MK Lobo","year":"2010","unstructured":"Lobo, M. K. et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330, 385\u2013390 (2010).","journal-title":"Science"},{"key":"1155_CR50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","volume":"81","author":"MA Hickey","year":"2002","unstructured":"Hickey, M. A., Reynolds, G. P. & Morton, A. J. The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington\u2019s disease. J. Neurochem. 81, 46\u201359 (2002).","journal-title":"J. Neurochem."},{"key":"1155_CR51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","volume":"97","author":"MA Johnson","year":"2006","unstructured":"Johnson, M. A., Rajan, V., Miller, C. E. & Wightman, R. M. Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease. J. Neurochem. 97, 737\u2013746 (2006).","journal-title":"J. Neurochem."},{"key":"1155_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","volume":"5","author":"JW Callahan","year":"2011","unstructured":"Callahan, J. W. & Abercrombie, E. D. In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington\u2019s disease. Front. Syst. Neurosci. 5, 61 (2011).","journal-title":"Front. Syst. Neurosci."},{"key":"1155_CR53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbr.2006.02.028","volume":"170","author":"C Cao","year":"2006","unstructured":"Cao, C. et al. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington\u2019s disease transgenic rat model. Behav. Brain Res. 170, 257\u2013261 (2006).","journal-title":"Behav. Brain Res."},{"key":"1155_CR54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2012.02.042","volume":"1450","author":"AN Ortiz","year":"2012","unstructured":"Ortiz, A. N. et al. Motor function and dopamine release measurements in transgenic Huntington\u2019s disease model rats. Brain Res. 1450, 148\u2013156 (2012).","journal-title":"Brain Res."},{"key":"1155_CR55","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s11064-015-1526-0","volume":"40","author":"U Winkler","year":"2015","unstructured":"Winkler, U. & Hirrlinger, J. Crosstalk of signaling and metabolism mediated by the NAD+\/NADH redox state in brain cells. Neurochem. Res. 40, 2394\u20132401 (2015).","journal-title":"Neurochem. Res."},{"key":"1155_CR56","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","volume":"43","author":"DA Lopez-Mora","year":"2016","unstructured":"Lopez-Mora, D. A. et al. Striatal hypometabolism in premanifest and manifest Huntington\u2019s disease patients. Eur. J. Nucl. Med. Mol. Imaging 43, 2183\u20132189 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1155_CR57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneumeth.2014.06.017","volume":"234","author":"YK Urbach","year":"2014","unstructured":"Urbach, Y. K. et al. Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington\u2019s disease. J. Neurosci. Methods 234, 38\u201353 (2014).","journal-title":"J. Neurosci. Methods"},{"key":"1155_CR58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jns.2016.11.075","volume":"372","author":"LE Almaguer-Mederos","year":"2017","unstructured":"Almaguer-Mederos, L. E. et al. Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2. J. Neurol. Sci. 372, 324\u2013328 (2017).","journal-title":"J. Neurol. Sci."},{"key":"1155_CR59","volume":"8","author":"AA Cook","year":"2022","unstructured":"Cook, A. A. et al. Activation of TrkB\u2013Akt signaling rescues deficits in a mouse model of SCA6. Sci. Adv. 8, eabh3260 (2022).","journal-title":"Sci. Adv."},{"key":"1155_CR60","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","volume":"92","author":"V Beaumont","year":"2016","unstructured":"Beaumont, V. et al. Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington\u2019s disease models. Neuron 92, 1220\u20131237 (2016).","journal-title":"Neuron"},{"key":"1155_CR61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/nu9070659","volume":"9","author":"J Kocot","year":"2017","unstructured":"Kocot, J., Luchowska-Kocot, D., Kielczykowska, M., Musik, I. & Kurzepa, J. Does vitamin C influence neurodegenerative diseases and psychiatric disorders? Nutrients 9, 659 (2017).","journal-title":"Nutrients"},{"key":"1155_CR62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1471-4159.2010.07151.x","volume":"116","author":"TD Aumann","year":"2011","unstructured":"Aumann, T. D. et al. Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons. J. Neurochem. 116, 646\u2013658 (2011).","journal-title":"J. Neurochem."},{"key":"1155_CR63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tem.2021.04.005","volume":"32","author":"B Podyma","year":"2021","unstructured":"Podyma, B., Parekh, K., Guler, A. D. & Deppmann, C. D. Metabolic homeostasis via BDNF and its receptors. Trends Endocrinol. Metab. 32, 488\u2013499 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"1155_CR64","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4427","volume":"5","author":"M Geibel","year":"2014","unstructured":"Geibel, M. et al. Ablation of TrkB signalling in CCK neurons results in hypercortisolism and obesity. Nat. Commun. 5, 3427 (2014).","journal-title":"Nat. Commun."},{"key":"1155_CR65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0896-6273(00)80853-3","volume":"24","author":"L Minichiello","year":"1999","unstructured":"Minichiello, L. et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401\u2013414 (1999).","journal-title":"Neuron"},{"key":"1155_CR66","first-page":"7.6.1","volume":"12","author":"J Lykkesfeldt","year":"2002","unstructured":"Lykkesfeldt, J. Measurement of ascorbic acid and dehydroascorbic acid in biological samples.Curr. Protoc. Toxicol. 12, 7.6.1\u20137.6.15 (2002).","journal-title":"Curr. Protoc. Toxicol."},{"key":"1155_CR67","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/nprot.2013.109","volume":"8","author":"A Lyubimova","year":"2013","unstructured":"Lyubimova, A. et al. Single-molecule mRNA detection and counting in mammalian tissue. Nat. Protoc. 8, 1743\u20131758 (2013).","journal-title":"Nat. Protoc."},{"key":"1155_CR68","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"1155_CR69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"1155_CR70","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & Kaller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"1155_CR71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"1155_CR72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/exnr.2002.8006","volume":"177","author":"B Georgievska","year":"2002","unstructured":"Georgievska, B., Kirik, D. & Bjorklund, A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177, 461\u2013474 (2002).","journal-title":"Exp. Neurol."},{"key":"1155_CR73","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/10430340252899019","volume":"13","author":"V Baekelandt","year":"2002","unstructured":"Baekelandt, V. et al. Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Hum. Gene Ther. 13, 841\u2013853 (2002).","journal-title":"Hum. Gene Ther."},{"key":"1155_CR74","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/2041-210X.12584","volume":"7","author":"O Friard","year":"2016","unstructured":"Friard, O. & Gamba, M. BORIS: a free, versatile open\u2010source event\u2010logging software for video\/audio coding and live observations. Methods Ecol. Evol. 7, 1325\u20131330 (2016).","journal-title":"Methods Ecol. Evol."},{"key":"1155_CR75","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1523\/JNEUROSCI.3639-07.2008","volume":"28","author":"DM Bannerman","year":"2008","unstructured":"Bannerman, D. M. et al. NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory. J. Neurosci. 28, 3623\u20133630 (2008).","journal-title":"J. Neurosci."},{"key":"1155_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101078","volume":"23","author":"S Badurek","year":"2020","unstructured":"Badurek, S. et al. Immature dentate granule cells require Ntrk2\/Trkb for the formation of functional hippocampal circuitry. iScience 23, 101078 (2020).","journal-title":"iScience"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01155-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01155-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01155-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T09:05:22Z","timestamp":1732611922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01155-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1038\/s42255-024-01155-z","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}